低流量先天性血管畸形的腔内治疗(附132例分析)  

Endovascular Treatment of Slow Flow Congenital Vascular Malformation: a Report of 132 Cases

作　　者：詹腾辉[1] 苏秋妮[2] 蔡方刚[1] 庄晖[1] 张金池[1] 刘学强[1] 吴捷[1] 戴贻权[1] 何天敏[1] 李先涛[1] 陈宏宇[1] 郭平凡[1] 

机构地区：[1]福建医科大学附属第一医院血管外科,福州350004 [2]厦门大学附属第一医院检验科,厦门361003

出　　处：《中国微创外科杂志》2016年第9期799-801,815,共4页Chinese Journal of Minimally Invasive Surgery

基　　金：国家临床重点专科建设项目(2013-GJLCZD);福建省中青年教师教育科技项目(JA14138)

摘　　要：目的总结低流量先天性血管畸形的腔内治疗经验。方法 2009年7月～2014年7月,对低流量先天性血管畸形132例,采用聚桂醇经皮硬化治疗61例,无水乙醇经皮硬化治疗3例,乙烯-乙烯基醇共聚物（ethylene vinyl alcohol copolymer,Onyx）经皮硬化2例,联合聚桂醇、无水乙醇、Onyx、平阳霉素或弹簧圈经皮硬化66例。结果随访6～66个月,平均18.8月。治愈57例（43.2%）,显效51例（38.6%）,好转18例（13.6%）,无效6例（4.5%）。1例（0.8%）治疗时发生一过性病灶疼痛。结论腔内治疗是低流量先天性血管畸形的有效治疗方案。Objective To review our experience of endovascular treatment for slow flow congenital vascular malformation. Methods From July 2009 to July 2014, 132 patients with slow flow congenital vascular malformation were treated in our hospital. The patients were treated with percutaneous sclerosing with lauromacrogol in 61 cases, with ethanol in 3 cases, with ethylene vinyl alcohol copolymer （Onyx） in 2 cases, and mixture of lauromacrogol, ethanol, Onyx, pingyangmycin or elastic ring in 66 cases. Results With a follow-up of 6-66 months （mean, 18.8 months）, 57 （43.2%） patients were found cured, 51 （38.6%） patients obtained obvious curative effects, 18 （13.6%） patients were improved, and 6 （4.5%） patients had no effect. One patient suffered transient lesion pain during the treatment （0.8%）. Conclusion Endovascular treatment is an effective treatment for slow flow congenital vascular malformation.

关 键 词：先天性血管畸形 低流量病灶 腔内治疗 

分 类 号：R654.3[医药卫生—外科学]